Title:
POLYSACCHARIDE-POLYAMINE COPOLYMER AND USE THEREOF IN REDUCING LOW DENSITY LIPOPROTEIN (LDL) CONCENTRATION IN PLASMA
Document Type and Number:
WIPO Patent Application WO/2016/150342
Kind Code:
A1
Abstract:
Disclosed is a pharmaceutical composition for treating hypercholesterolemia. The pharmaceutical composition comprises a polysaccharide-polyamine copolymer and a pharmaceutically acceptable salt thereof as active ingredients. The polysaccharide-polyamine copolymer is formed by copolymerization of the following two parts: a selectively oxidized polysaccharide with 2,3-dialdehydo, and a polyamine with an amino functional group; the polyamine with an amino functional group and the selectively oxidized polysaccharide with 2,3-dialdehydo can form a net structure by means of covalent crosslinking, resulting in a hydrogel with an amino functional group or a granular polysaccharide-polyamine copolymer, wherein the amino functional group in the hydrogel with an amino functional group or the granular polysaccharide-polyamine copolymer can be protonated so as to form a cationic copolymer of a three-dimensional network structure having a protonated site, and the nitrogen content of the cationic copolymer and the nitrogen content of the polysaccharide-polyamine copolymer are above 12.3 wt%, and both the cationic copolymer and the polysaccharide-polyamine copolymer are water-insoluble.
Inventors:
YANG DAZHI (CN)
Application Number:
PCT/CN2016/076716
Publication Date:
September 29, 2016
Filing Date:
March 18, 2016
Export Citation:
Assignee:
YANG DAZHI (CN)
International Classes:
C08B37/00; A61P3/06; C08B15/02; C08B15/06
Domestic Patent References:
| WO2000021572A2 | 2000-04-20 |
Foreign References:
| CN101791408A | 2010-08-04 | |||
| CN102154351A | 2011-08-17 | |||
| CN102154350A | 2011-08-17 | |||
| CN103113594A | 2013-05-22 |
Attorney, Agent or Firm:
LIU, SHEN & ASSOCIATES (CN)
北京市柳沈律师事务所 (CN)
北京市柳沈律师事务所 (CN)
Download PDF: